ACLS Strangle Strategy

ACLS (Axcelis Technologies, Inc.), in the Technology sector, (Semiconductors industry), listed on NASDAQ.

Axcelis Technologies, Inc. is a company dedicated to the creation, production, and maintenance of specialized ion implantation and other essential processing machinery used in the fabrication of semiconductor chips. Operating internationally, its presence extends across North America, Europe, and Asia. The firm offers a wide array of implanter technologies, such as high-energy, high-current, and medium-current systems, designed to meet diverse application needs. Furthermore, Axcelis provides extensive post-sales support and lifecycle solutions, including the sale of pre-owned equipment, replacement parts, system upgrades, ongoing maintenance, and client instruction. It directly furnishes its advanced equipment and services to microchip manufacturers through its own dedicated sales personnel. Founded in 1978, Axcelis Technologies has its corporate headquarters situated in Beverly, Massachusetts.

ACLS (Axcelis Technologies, Inc.) trades in the Technology sector, specifically Semiconductors, with a market capitalization of approximately $5.32B, a trailing P/E of 52.76, a beta of 1.92 versus the broader market, a 52-week range of 65.64-193.78, average daily share volume of 682K, a public-listing history dating back to 2000, approximately 2K full-time employees. These structural characteristics shape how ACLS stock options price implied volatility around earnings windows, capital events, and macro-driven sector rotations.

A beta of 1.92 indicates ACLS has historically moved more than the broader market, amplifying both the directional payoff and the realized volatility relative to an index-equivalent position. The trailing P/E of 52.76 is on the rich side, which tends to correlate with higher earnings-window IV expansion as the market debates whether forward growth supports the multiple.

What is a strangle on ACLS?

A long strangle buys an OTM call and an OTM put at offset strikes, cheaper than a straddle but requiring a larger underlying move to profit since both wings start out-of-the-money.

Current ACLS snapshot

As of June 30, 2026, spot at $189.12, ATM IV 87.40%, IV rank 73.81%, expected move 25.06%. The strangle on ACLS below is built from the same end-of-day chain, with strikes snapped to listed contracts and premiums pulled from the bid/ask midpoint at a 17-day expiry.

Why this strangle structure on ACLS specifically: ACLS IV at 87.40% is rich versus its 1-year range, which makes a premium-buying ACLS strangle relatively expensive in absolute-cost terms, with a market-implied 1-standard-deviation move of approximately 25.06% (roughly $47.39 on the underlying). The 17-day window matched to the front-month expiry keeps theta exposure bounded while still capturing the post-snapshot move; longer-dated ACLS expiries trade a higher absolute premium for lower per-day decay. Position sizing on ACLS should anchor to the underlying notional of $189.12 per share and to the trader's directional view on ACLS stock.

ACLS strangle setup

The ACLS strangle below is built from the end-of-day chain, with each option leg priced at the bid/ask midpoint of its listed strike. With ACLS near $189.12, the first option leg uses a $200.00 strike; additional legs (when the strategy has them) anchor to spot-relative offsets. Premiums come from the bid/ask midpoint on the listed ACLS chain at a 17-day expiry; the cross-strike IV skew is reflected directly in the per-leg values rather than approximated. Quantity sizing assumes one contract per option leg (or 100 ACLS shares for the stock leg in covered calls and collars).

ActionTypeStrike / BasisPremium (est)
Buy 1Call$200.00$9.95
Buy 1Put$180.00$9.70

ACLS strangle risk and reward

Net Premium / Debit
-$1,965.00
Max Profit (per contract)
Unbounded
Max Loss (per contract)
-$1,965.00
Breakeven(s)
$160.35, $219.65
Risk / Reward Ratio
Unbounded

Upside max profit is unbounded; downside max profit is bounded at the put strike minus the combined debit (reached at zero). Max loss equals the combined debit times 100 (reached anywhere between the two OTM strikes). Two breakevens at call-strike plus debit and put-strike minus debit.

ACLS strangle payoff curve

Modeled P&L at expiration across a range of underlying prices for the strangle on ACLS. Each row is one sampled price point from the computed payoff curve; the full curve uses 200 price points internally before being summarized into 10 rows here.

ACLS strangle profit and loss curve at expiration with breakevens and current spot markedACLS strangle payoff at expiration$0$5000$10000$15000$50$100$150$200$250$300$350Underlying Price ($)P&L at Expiration ($)BE $160.35BE $219.65Spot $189.12
P&L at expiration across the modeled underlying-price range. Green shading marks profitable regions, red shading marks loss regions. Dotted purple verticals mark breakevens; the solid dark vertical marks current spot.
Underlying Price% From SpotP&L at Expiration
$0.01-100.0%+$16,034.00
$41.82-77.9%+$11,852.56
$83.64-55.8%+$7,671.13
$125.45-33.7%+$3,489.69
$167.27-11.6%-$691.75
$209.08+10.6%-$1,056.81
$250.90+32.7%+$3,124.62
$292.71+54.8%+$7,306.06
$334.52+76.9%+$11,487.50
$376.34+99.0%+$15,668.93

When traders use strangle on ACLS

Strangles on ACLS are the cheaper cousin of the straddle - traders use them when they want a large directional move but are willing to give up the inner-strike sensitivity in exchange for a lower up-front debit on the ACLS chain.

ACLS thesis for this strangle

The market-implied 1-standard-deviation range for ACLS extends from approximately $141.73 on the downside to $236.51 on the upside. A ACLS long strangle is the OTM cousin of the straddle: lower up-front cost but the underlying has to travel further past either OTM strike before the position turns profitable at expiration. Current ACLS IV rank near 73.81% sits in the upper third of its 1-year distribution, which historically reverts; this raises the bar for premium-buying structures and lowers it for premium-selling structures on ACLS at 87.40%. As a Technology name, ACLS options can move on sector-level news flow (peer earnings, regulatory updates, industry-specific macro data) in addition to ACLS-specific events.

ACLS strangle positions are structurally neutral / high-volatility (long premium, OTM); the modeled P&L assumes European-style exercise at expiration and ignores early assignment, transaction costs, dividends paid before expiry on the stock leg (when present), and the bid-ask spread on the listed chain. ACLS positions also carry Technology sector concentration risk; news flow inside the sector (peer earnings, regulatory shifts, supply-chain headlines) can move ACLS alongside the broader basket even when ACLS-specific fundamentals are unchanged. Always rebuild the position from current ACLS chain quotes before placing a trade.

Frequently asked questions

What is a strangle on ACLS?
A strangle on ACLS is the strangle strategy applied to ACLS (stock). The strategy is structurally neutral / high-volatility (long premium, OTM): A long strangle buys an OTM call and an OTM put at offset strikes, cheaper than a straddle but requiring a larger underlying move to profit since both wings start out-of-the-money. With ACLS stock trading near $189.12, the strikes shown on this page are snapped to the nearest listed ACLS chain strike and the premiums come straight from the end-of-day bid/ask midpoint.
How are ACLS strangle max profit and max loss calculated?
Upside max profit is unbounded; downside max profit is bounded at the put strike minus the combined debit (reached at zero). Max loss equals the combined debit times 100 (reached anywhere between the two OTM strikes). Two breakevens at call-strike plus debit and put-strike minus debit. For the ACLS strangle priced from the end-of-day chain at a 30-day expiry (ATM IV 87.40%), the computed maximum profit is unbounded per contract and the computed maximum loss is -$1,965.00 per contract. Live intraday quotes will differ as the chain moves through the trading session.
What is the breakeven for a ACLS strangle?
The breakeven for the ACLS strangle priced on this page is roughly $160.35 and $219.65 at expiration, derived from end-of-day chain premiums. Breakeven is the underlying price at which the strategy's P&L crosses zero ignoring transaction costs and assignment risk. The current ACLS market-implied 1-standard-deviation expected move is approximately 25.06%; if the move sits well outside the breakeven distance, the structure's risk-reward becomes correspondingly tighter.
When should you consider a strangle on ACLS?
Strangles on ACLS are the cheaper cousin of the straddle - traders use them when they want a large directional move but are willing to give up the inner-strike sensitivity in exchange for a lower up-front debit on the ACLS chain.
How does current ACLS implied volatility affect this strangle?
ACLS ATM IV is at 87.40% with IV rank near 73.81%, which is elevated relative to its 1-year range. Premium-selling structures (covered call, cash-secured put, iron condor) generally look more attractive when IV rank is high; premium-buying structures (long call, long put, debit spreads) are more expensive in that regime.

Related ACLS analysis